Immunai integrates AI with immunology to transform medical innovation. Mikael Dolsten, former Pfizer CSO, joins Immunai's Board, bringing expertise in drug development and past successes like the mRNA COVID-19 vaccine.…
Oncolytics Biotech Inc. faces financial challenges, reporting a Q4 2024 net loss of $8 million and declining cash reserves. The company’s flagship oncolytic virus, pelareorep, shows promise in cancer therapeutics,…
Tevogen Bio leverages AI to revolutionize precision medicine, merging proprietary datasets with generative AI models. The company's approach focuses on transforming therapeutic applications from generalized to highly personalized treatments. AI's…
Automation, powered by advanced AI, is transforming laboratories, enhancing precision and efficiency. Robotic systems boost throughput, reliability, and scalability, crucial for fields like drug discovery and genomics. AI-driven algorithms help…
Marker Therapeutics is highly rated by Canaccord Genuity for its innovative cancer cell therapies, aiming for an target price from . Krystal Biotech garners a strong buy from Jefferies, targeting…
Colossal Biosciences aims to resurrect the woolly mammoth, extinct for millennia, potentially being the first de-extinct species brought back by 2028. The "woolly mouse," engineered with mammoth genes, exhibits traits…
Krystal Biotech is experiencing a significant rise in short interest, with 14.58% of its shares sold short. This increase signifies a shift in investor sentiment, implying expectations of a short-term…
Wisconsin is emerging as a hotspot for biotechnology, driven by both established companies and new ventures. Epic Systems in Verona leads in healthcare technology, creating networks that connect patients and…
Warm Fusion is set in a dystopian future New York City, blending elements of cyberpunk and noir. The storyline follows detective Jarrod Hannover and escort Vin Young, known as Snow…
Aardvark Therapeutics launches its IPO, marking the first life science IPO of 2025 in San Diego, with its stock starting at $16 on Nasdaq. The company focuses on small molecule…